A G Hirsch1, J Pollak2,3, T A Glass4, M N Poulsen1,2, L Bailey-Davis1, J Mowery1, B S Schwartz1,2,4. 1. Department of Epidemiology and Health Services Research, Geisinger Health System, Danville, PA, USA. 2. Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Abstract
BACKGROUND: Antibiotic use in early life has been linked to disruptions in the microbiome. Such changes can disturb immune system development. Differences have been observed in the microbiota of children with and without allergies, but there have been few studies on antibiotic use and allergic disease. OBJECTIVE: We evaluated associations of early-life antibiotic use with subsequent occurrence of food allergy and other allergies in childhood using electronic health record data. METHODS: We used longitudinal data on 30 060 children up to age 7 years from Geisinger Clinic's electronic health record to conduct a sex- and age-matched case-control study to evaluate the association between antibiotic use and milk allergy, non-milk food allergies, and other allergies. For each outcome, we estimated conditional logistic regression models adjusting for race/ethnicity, history of Medical Assistance, and mode of birth delivery. Models were repeated separately for penicillins, cephalosporins and macrolides. RESULTS: There were 484 milk allergy cases, 598 non-milk food allergy cases and 3652 other allergy cases. Children with three or more antibiotic orders had a greater odds of milk allergy (Odds Ratio; 95% Confidence interval) (1.78; 1.28-2.48), non-milk food allergy (1.65; 1.27-2.14), and other allergies (3.07; 2.72-3.46) compared with children with no antibiotic orders. Associations were strongest at younger ages and differed by antibiotic class. CONCLUSIONS AND CLINICAL RELEVANCE: We observed associations between antibiotic orders and allergic diseases, providing evidence of a potentially modifiable clinical practice associated with paediatric allergic disease. Differences by antibiotic class should be further explored, as this knowledge could inform paediatric treatment decisions.
BACKGROUND: Antibiotic use in early life has been linked to disruptions in the microbiome. Such changes can disturb immune system development. Differences have been observed in the microbiota of children with and without allergies, but there have been few studies on antibiotic use and allergic disease. OBJECTIVE: We evaluated associations of early-life antibiotic use with subsequent occurrence of food allergy and other allergies in childhood using electronic health record data. METHODS: We used longitudinal data on 30 060 children up to age 7 years from Geisinger Clinic's electronic health record to conduct a sex- and age-matched case-control study to evaluate the association between antibiotic use and milk allergy, non-milk food allergies, and other allergies. For each outcome, we estimated conditional logistic regression models adjusting for race/ethnicity, history of Medical Assistance, and mode of birth delivery. Models were repeated separately for penicillins, cephalosporins and macrolides. RESULTS: There were 484 milk allergy cases, 598 non-milk food allergy cases and 3652 other allergy cases. Children with three or more antibiotic orders had a greater odds of milk allergy (Odds Ratio; 95% Confidence interval) (1.78; 1.28-2.48), non-milk food allergy (1.65; 1.27-2.14), and other allergies (3.07; 2.72-3.46) compared with children with no antibiotic orders. Associations were strongest at younger ages and differed by antibiotic class. CONCLUSIONS AND CLINICAL RELEVANCE: We observed associations between antibiotic orders and allergic diseases, providing evidence of a potentially modifiable clinical practice associated with paediatric allergic disease. Differences by antibiotic class should be further explored, as this knowledge could inform paediatric treatment decisions.
Authors: Juan C Celedón; Augusto A Litonjua; Louise Ryan; Scott T Weiss; Diane R Gold Journal: Am J Respir Crit Care Med Date: 2002-07-01 Impact factor: 21.405
Authors: Thomas R Abrahamsson; Hedvig E Jakobsson; Anders F Andersson; Bengt Björkstén; Lars Engstrand; Maria C Jenmalm Journal: J Allergy Clin Immunol Date: 2011-12-06 Impact factor: 10.793
Authors: Ana Elena Pérez-Cobas; Alejandro Artacho; Henrik Knecht; María Loreto Ferrús; Anette Friedrichs; Stephan J Ott; Andrés Moya; Amparo Latorre; María José Gosalbes Journal: PLoS One Date: 2013-11-25 Impact factor: 3.240
Authors: Grace C Lee; Kelly R Reveles; Russell T Attridge; Kenneth A Lawson; Ishak A Mansi; James S Lewis; Christopher R Frei Journal: BMC Med Date: 2014-06-11 Impact factor: 8.775
Authors: Erin K Willits; Miguel A Park; Martha F Hartz; Cathy D Schleck; Amy L Weaver; Avni Y Joshi Journal: Mayo Clin Proc Date: 2018-10 Impact factor: 7.616
Authors: Edward Mitre; Apryl Susi; Laura E Kropp; David J Schwartz; Gregory H Gorman; Cade M Nylund Journal: JAMA Pediatr Date: 2018-06-04 Impact factor: 16.193
Authors: Miren B Dhudasia; Jonathan M Spergel; Karen M Puopolo; Corinna Koebnick; Matthew Bryan; Robert W Grundmeier; Jeffrey S Gerber; Scott A Lorch; William O Quarshie; Theoklis Zaoutis; Sagori Mukhopadhyay Journal: Pediatrics Date: 2021-04-08 Impact factor: 7.124
Authors: Rod A Herman; Patricia A Bauman; Laurie Goodwin; Emir Islamovic; Eric H Ma; Hector Serrano; Andre Silvanovich; Abigail R Simmons; Ping Song; Afua O Tetteh; Rong Wang Journal: Transgenic Res Date: 2021-04-16 Impact factor: 2.788
Authors: Annemarie G Hirsch; T Elizabeth Durden; Cara Nordberg; Andrea Berger; Brian S Schwartz Journal: Diabetes Care Date: 2017-12-19 Impact factor: 19.112